Yale cancer specialist Charlie Fuchs tapped as new global development chief for Roche/Genentech
Roche and their big sub Genentech have just recruited a top cancer specialist at Yale to head up global product development in oncology and hematology.
I just got word that the pharma giant, which leads one of the most active cancer research operations in the world, recruited Charlie Fuchs, director of the Yale Cancer Center and physician-in-chief of Smilow Cancer Hospital. He’ll join the global operation March 1 and will be based in South San Francisco, where Genentech is based.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 102,300+ biopharma pros reading Endpoints daily — and it's free.